Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Karl B Kern , Sergio Timerman , José Antônio Franchini Ramires Added: 3 years ago
Cardiocerebral resuscitation (CCR) is a relatively new approach to the resuscitation of patients with out-of-hospital cardiac arrest (see Figure 1). By 2003, both the accumulated resuscitation research data and our own local clinical experience in Tucson, Arizona clearly indicated that interruptions of chest compressions had a negative effect on survival. Accordingly, in November 2003 in co… View more
Author(s): Derek Connolly , , Added: 2 years ago
According to NICE,HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation. Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per… View more
Author(s): Sitaramesh Emani , William T Abraham Added: 3 years ago
Heart failure (HF) is a growing epidemiological challenge in the US and worldwide. In the US, it is estimated that at least 5 million people are affected by it, with more than a half-million new diagnosis being made each year.1 Despite major improvements in the treatment of HF, almost 30 % of patients treated for acute HF require readmission within 30 days.2,3 These sobering statistics underscore… View more
Author(s): Frédéric Michard Added: 3 years ago
Volume expansion is one of the most common therapeutic procedures in intensive care units (ICUs). There is no doubt that in some cases (e.g. hemorrhage or severe diarrhea) care-givers can reasonably rely on clinical examination to identify patients who will benefit from fluid loading. However, in more complex—but not uncommon—situations (e.g. septic shock), both clinical examination and… View more
Author(s): Michael D McGoon Added: 3 years ago
Pulmonary hypertension (PH) is a hemodynamic condition defined by pulmonary arterial systolic pressure (PASP) above an upper limit of 35mmHg, or by pulmonary arterial mean pressure (PAMP) exceeding 25mmHg at rest.1,2 Pulmonary arterial hypertension (PAH) is present when pre-capillary pulmonary vascular pressure is elevated in the absence of pulmonary capillary wedge pressure >15mmHg, such as… View more
Author(s): Robert F Riley , James M McCabe Added: 3 years ago
Heart disease remains the leading cause of death in the US, with ischemic heart disease comprising almost half of these deaths based on the most recent 2013 mortality data.1 While there have been reports of declining rates of acute myocardial infarction (AMI) from various registries and Medicare beneficiary reports, coronary heart disease remained the underlying cause of death in one out of seven… View more
Author(s): Hossein-Ardeschir Ghofrani , Ralph T Schermuly , Norbert Weissmann , et al Added: 3 years ago
Pulmonary arterial hypertension (PAH) has an estimated prevalence of 15–25 cases/million population.1 This chronic, progressive disease is defined by a mean pulmonary arterial pressure >25mmHg in conjunction with normal pulmonary capillary wedge pressure <15mmHg.2 The disease is characterized by increased vascular resistance of the pulmonary microvasculature, ultimately resulting in right… View more
Author(s): Geoffrey Houlton Added: 3 years ago
Cardiovascular (heart) disease is the cause of more deaths in the western world than all other forms of disease. In the coming years this problem is predicted to escalate as the majority of the ‘baby boomer’ generation will be well into retirement. As a result, technologies that improve the assessment of or aid in the detection of heart disease will become increasingly important in patient… View more